An Observational Cohort Study of the Risk of Thromboembolic Events Among Adult Patients Treated With KCENTRA Compared With Plasma for Urgent Reversal of Vitamin K Antagonist Therapy in the Setting of Acute Major Bleeding

Trial Profile

An Observational Cohort Study of the Risk of Thromboembolic Events Among Adult Patients Treated With KCENTRA Compared With Plasma for Urgent Reversal of Vitamin K Antagonist Therapy in the Setting of Acute Major Bleeding

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 Apr 2017

At a glance

  • Drugs Prothrombin complex concentrate (Primary) ; Plasma
  • Indications Haemorrhage
  • Focus Adverse reactions
  • Sponsors CSL Behring
  • Most Recent Events

    • 24 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top